Biologics Extremities Regulatory Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA byJosh SandbergApril 3, 2023
Financial Injectable Cement Market to Garner $2.29 Bn, Globally, by 2031 at 5.7% CAGR: Allied Market Research byJosh SandbergNovember 23, 2022
Biologics Neuro Spine SmartTRAK Advances Medtech Market Insights Platform; Announces New Modules for Wound Care and Orthopedic/Spine Injectables byChris StewartNovember 9, 2022
Biologics Spine Top Stories Bone Solutions Launches Mg OSTEOINJECT Injectable Magnesium-Based Bone Void Filler byJosh SandbergJanuary 25, 2022
Biologics Recon Anika Announces Successful Completion of First Human Surgical Procedure with Injectable HA-Based Bone Repair Therapy byJosh SandbergAugust 13, 2019
Top Stories Injectable sponges used for first time to stop soldier’s bleeding byJosh SandbergMay 31, 2016
Recon New Data From Oxford University Hospitals Demonstrate Superior Outcome With CERAMENT™ Antibiotic Eluting Bone Substitute Compared To Collagen And Calcium Sulfate In The Management Of Chronic Osteomyelitis byJosh SandbergOctober 7, 2015
Hospitals GRAFTYS Announces the Extension of its CE Mark for Its Calcium Phosphate Cements to Now Include GRAFTYS® HBS and GRAFTYS® Quickset for the Indication of Subchondral Bone Marrow Lesions around the Knee Joint (BML) byJosh SandbergSeptember 14, 2015
